Reduce Uncertainty in Kinase Screening

Low-activity or inconsistent kinases can produce weak signals, shallow inhibition curves, and unreliable IC₅₀ values, making it difficult to distinguish real hits from assay variability.

SignalChem Biotech’s portfolio of 1,100+ highly active kinases, including 400+ clinically relevant mutants, helps deliver:

• Stronger signals and wider dynamic ranges

• More precise IC₅₀ and potency measurements

• Better reproducibility across experiments

• Greater confidence in hit selection and lead optimization

With custom kinase production and assay development services available, Sino Biological helps you generate data you can trust.

More information here.